YY/T 1164-2021Human chorionic gonadotropin (HCG) detection kit (colloidal gold immunochromatographic assay) (English PDF)
人绒毛膜促性腺激素(HCG)检测试剂盒(胶体金免疫层析法)
This is a limited preview
Buy now to download the full PDF (23 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1164-2021 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
December 6, 2021
Implementation date
December 1, 2022
Scope
YY/T 1164-2021 is the English-translated version of 人绒毛膜促性腺激素(HCG)检测试剂盒(胶体金免疫层析法).
YY/T 1164-2021 is the Chinese pharmaceutical industry standard for the human chorionic gonadotropin test strip based on colloidal gold immunochromatography, the pregnancy test read from a urine sample.
It gives the terms and definitions, the technical requirements, the test methods, the labels and instructions for use and the rules for packaging, transport and storage, the requirements covering appearance, the detection limit, the absence of a false result on negative and positive references, the hook effect at high concentrations, repeatability and stability.
It applies to strips for the qualitative and semi-quantitative detection of HCG in human urine. It replaces YY/T 1164-2009, was issued on 6 December 2021 and has applied since 1 December 2022.
Found what you need?
Document preview — YY/T 1164-2021
National Standard of the People's Republic of China
- Classification
- C 44
- Replacing
- YY/T 1164-2009
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Foreword
- 1 Scope
- 2 Normative references
- 3 Terms and Definitions
Foreword
This document is in accordance with the provisions of GB/T 1.1-2020 "Standardization Work Guidelines Part 1. Structure and Drafting Principles of Standardization Documents" drafted.
This document replaces YY/T 1164-2009 "Human Chorionic Gonadotropin (HCG) Test Strip (Colloidal Gold Immunochromatography)", and Compared with YY/T 1164-2009, in addition to editorial changes, the main technical changes are as follows:
--- Added normative references GB/T 29791.1-2013, GB/T 29791.2; deleted the diagnosis of human chorionic gonadotropin Procedures for the manufacture and inspection of reagents (colloidal gold method) (2000) (see Chapter 2, Chapter 2 of the:2009 edition);
---Added qualitative detection, semi-quantitative detection, detection limit, C5~C95 interval in terms and definitions; deleted human chorionic gonadotropin Terms and definitions of test strips (see Chapter 3, Chapter 3 of the:2009 edition);
--- Modified the width requirements and corresponding detection methods (see 4.1.2 and 5.2.2, 4.1.2 and 5.3.2 of the:2009 edition);
--- Modified the requirements for the speed of movement and the corresponding detection methods (see 4.1.3 and 5.2.3, 4.1.3 and 5.3.3 of the:2009 edition);
--- Modified the detection limit requirements and corresponding detection methods (see 4.1.4 and 5.2.4, 4.2 and 5.4 of the:2009 edition);
--- Modified negative specificity and positive specificity, unified as specificity (see 4.1.5, 4.3 of the:2009 edition);
--- Added semi-quantitative requirements and corresponding detection methods (see 4.2 and 5.3);
--- Modified the provisions of labels and instructions for use (see Chapter 7 of the:2009 edition);
--- Increased packaging should comply with the provisions of GB/T 191 (see 7.1).
1 Scope
This document specifies the human chorionic gonadotropin (HCG) detection kit (colloidal gold immunoassay)
Immunochromatography) (hereinafter referred to as HCG test strip) terms and definitions, technical requirements, test methods, labels and instructions for use, packaging, transportation, storage.
This document is applicable to the qualitative and semi-quantitative detection of HCG content in human urine samples based on the principle of colloidal gold immunochromatography. Reagent test kit.
2 Normative references
The contents of the following documents constitute essential provisions of this document through normative references in the text. Among them, dated citations documents, only the version corresponding to that date applies to this document; for undated references, the latest edition (including all amendments) applies to this document.
GB/T 191 Graphical signs of packaging, storage and transportation
GB/T 29791.1-2013 Information provided by manufacturers of in vitro diagnostic medical devices (labeling) Part 1. Terms, definitions and common enquiries
GB/T 29791.2 Information provided by manufacturers of in vitro diagnostic medical devices (labeling) Part 2. In vitro diagnostic reagents for professional use
3 Terms and Definitions
The terms and definitions defined in GB/T 29791.1-2013 and the following apply to this document.
3.1 Qualitative examination
A set of operations to identify or classify substances based on their chemical or physical properties.
Note 1. Generally only two types of test results (positive/negative, yes/no, yes/no, etc:) are reported.
Note 2 to entry. It is distinguished by the fact that there is only one possible medical decision point at the critical value. [Source: GB/T 29791.1-2013, A:3.43, with modifications]
3.2 Semiquantitativeexamination
Essentially a qualitative test with added response level options (positive level, dilution to get a positive result, or comparison to a color chart).
The response results can be presented using an ordinal scale, etc.
Example: Test results can be reported as "-" "±" " "" " ". [Source: EP19(2nded), 1.4.2]
3.3 Detection limit
The measured value obtained by a given measurement procedure, for which, given the probability of misjudgment of the presence of a component in the claimed substance, alpha, the sound is The misjudgment probability of the absence of this component is called beta.
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 23 pages — is available in the English PDF.
Referenced standards
Normative references
- GB/T 191Graphical symbols marking for handling and storage of packages
- GB/T 29791.1-2013In vitro diagnostic medical devices -- Information supplied by the manufacturer (labelling) -- Part 1: Terms, definitions and general requirements
- GB/T 29791.2In vitro diagnostic medical devices -- Information supplied by the manufacturer (labelling) -- Part 2: In vitro diagnostic reagents for professional use
Similar standards
Editions of YY/T 1164
| Edition | Title | Revision | Status |
|---|---|---|---|
| YY/T 1164-2021 | Human chorionic gonadotropin (HCG) detection kit (colloidal gold immunochromatographic assay) | current edition | Current |
| YY/T 1164-2009 | Human chorionic gonadotropin (HCG) detection kit (colloidal gold immunochromatographic assay) | previous edition | Superseded |
This page sells the current edition, YY/T 1164-2021. Earlier editions are listed for reference only.
How to Download YY/T 1164-2021
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 191-2025 — Graphical symbols marking for handling and storage of packages
GB/T 29791.1-2013 — In vitro diagnostic medical devices -- Information supplied by the manufacturer (labelling) -- Part 1: Terms, definitions and general requirements
GB/T 29791.2-2013 — In vitro diagnostic medical devices -- Information supplied by the manufacturer (labelling) -- Part 2: In vitro diagnostic reagents for professional use
Secure payment via Stripe
Payments accepted
YY/T 1164-2021
$150.00